We know about the importance of disease-modifying therapy (DMT) in managing MS and slowing its progression. But you may not know that there are two very different schools of thought when it comes to how and why your neurologist may recommend one DMT over another. My guest is Dr. Aaron Boster, the System Medical Chief for Neuroimmunology at OhioHealth, and we're talking about an important conversation that you should be having with your neurologist.

We're also talking about the newly published clinical trial results that demonstrate that stem cell therapy may be more effective than DMT in managing disease progression among people living with relapsing-remitting MS. We'll tell you about a study that shows how mindfulness can be valuable in improving the well-being for people living with MS, we'll tell you about this year's winner of the National MS Society's Barancik Prize for Innovation in MS Research, and if you're living with secondary progressive MS, we'll tell you about a survey that you should really participate in.

We have a lot to talk about! Are you ready for RealTalk MS?! ___________

Stem Cell Therapy More Effective Than DMT in Managing Progression in Relapsing-Remitting MS   1:27

Mindfulness Improves Well-Being for People Living with MS  4:21

Stress, Depression & Fatigue Impact Caregiver Health Status  6:19

National MS Society Announces Barancik Prize for Innovation in MS Research  7:22

An Important Survey for People with Secondary Progressive MS  9:27

My Interview with Dr. Aaron Boster  11:58

___________

SHARE YOUR FEEDBACK, QUESTIONS, AND IDEAS

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.

Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]

Phone: (310) 526-2283

___________

LINKSIf your podcast app doesn’t allow you to click on these links, you’ll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

STUDY: Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis

STUDY: Longitudinal Associations Between Mindfulness and Well-Being in People with Multiple Sclerosis

STUDY: Quality of Life and Emotional Strain in Caregivers of Patients with Multiple Sclerosis

MS Coalition/ICER Survey About Secondary-Progressive MS

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 74 Hosted By: Jon Strum Guest: Dr. Aaron Boster

Tags: MS, MultipleSclerosis, MSResearch, OhioHealthMS, HSCT, Mindfulness, Caregiver, Caregiving, MSSociety, ICER, RealTalkMS